|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | |
---|
|
Oshaughnessy, 2001 | capecitabine | CMF | | | | - | |
Joensuu, 2009 NCT | capecitabine | control | | | Risk of bias | - | |
Stockler, 2011 | capecitabine | cyclophosphamide, methotrexate, and 5-fluorouracil | | | | - | |
GeparQuattro, 2010 NCT | capecitabine docetaxel | docetaxel | | | | - | |
Mavroudis, 2010 | capecitabine | docetaxel + epirubicin | | | | - | |
Verma, 2005 | capecitabine + docetaxel | docetaxel alone | | | | - | |
Miles, 2004 | capecitabine + docetaxel | docetaxel alone | | | | - | |
O'Shaughnessy, 2002 | capecitabine + docetaxel | docetaxel alone | | | | - | |
Lee, 2008 | capecitabine + docetaxel | doxorubicin + cyclophosphamide | | | | - | |
Hori | capecitabine MPA | IV CT | | | | - | |
Talbot, 2002 | capecitabine | paclitaxel | | | | - | |
Moiseenko, 2000 | capecitabine | paclitaxel | | | | - | |
Jäger, 2010 | capecitabine | pegylated liposomal doxorubicin | | | | - | |
EORTC 10001 (Pajk), 2008 | capecitabine | vinorelbine | | | | - | |